Structures by: Wagner T.
Total: 56
LoratadineI-m100(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.997(4)Å b=4.918(1)Å c=28.971(4)Å
α=90.00° β=108.987(1)° γ=90.00°
Loratadine-form2-He
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=35.652(10)Å b=5.206(2)Å c=22.743(6)Å
α=90.00° β=117.418(14)° γ=90.00°
LoratadineI-p80(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.502(15)Å b=5.051(4)Å c=29.231(16)Å
α=90.00° β=109.51(3)° γ=90.00°
LoratadineI-p25
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.301(4)Å b=4.998(1)Å c=29.154(4)Å
α=90.00° β=109.217(6)° γ=90.00°
LoratadineI-0deg(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.201(6)Å b=4.9720(10)Å c=29.106(7)Å
α=90.00° β=109.077(10)° γ=90.00°
LoratadineI-m173(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.906(4)Å b=4.8860(10)Å c=28.927(5)Å
α=90.00° β=109.016(5)° γ=90.00°
C28H38NO6P
C28H38NO6P
Journal of medicinal chemistry (2005) 48, 16 5373-5377
a=6.413(5)Å b=13.141(9)Å c=17.092(9)Å
α=82.02(2)° β=86.30(2)° γ=76.29(2)°
ABIV-284
C17H17N3
Organic letters (2011) 13, 2 192-195
a=12.632(3)Å b=9.666(2)Å c=12.804(3)Å
α=90.00° β=116.024(7)° γ=90.00°
ABIV-293
C17H18N2O2
Organic letters (2011) 13, 2 192-195
a=8.782(4)Å b=19.177(8)Å c=9.362(4)Å
α=90.00° β=113.90(2)° γ=90.00°
C32H56O7,7(H2O)
C32H56O7,7(H2O)
Organic letters (2011) 13, 6 1354-1357
a=50.084(4)Å b=5.9938(6)Å c=13.2247(10)Å
α=90° β=105.051(4)° γ=90°
C32H52O6,2.38(H2O)
C32H52O6,2.38(H2O)
Organic letters (2011) 13, 6 1354-1357
a=6.4777(15)Å b=16.504(5)Å c=29.762(7)Å
α=90° β=90° γ=90°
NapNCAuBr
C11H7AuBrN
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14712-14723
a=38.18(5)Å b=4.131(5)Å c=13.354(12)Å
α=90° β=96.66(5)° γ=90°
NapNCAuI
C11H7AuIN
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14712-14723
a=4.7397(3)Å b=9.8038(6)Å c=12.3826(7)Å
α=99.575(3)° β=91.594(3)° γ=98.130(3)°
1:1 pico:sal
C13H12N2O4
CrystEngComm (2014) 16, 21 4365
a=13.595(5)Å b=3.710(2)Å c=24.063(9)Å
α=90.00° β=100.080(18)° γ=90.00°
2:1 pico:succ
C16H18N4O6
CrystEngComm (2014) 16, 21 4365
a=32.561(10)Å b=5.078(2)Å c=20.831(6)Å
α=90.00° β=105.811(13)° γ=90.00°
2:1 pico:fum
C8H8N2O3
CrystEngComm (2014) 16, 21 4365
a=8.479(3)Å b=4.979(2)Å c=19.167(7)Å
α=90.00° β=90.083(18)° γ=90.00°
2:1 pico:adi
C9H11N2O3
CrystEngComm (2014) 16, 21 4365
a=7.546(2)Å b=11.745(3)Å c=10.595(3)Å
α=90.00° β=90.210(13)° γ=90.00°
1:1 pico:adi
C12H16N2O5
CrystEngComm (2014) 16, 21 4365
a=7.006(2)Å b=20.510(6)Å c=9.125(3)Å
α=90.00° β=106.06(2)° γ=90.00°
Pico form I
C6H6N2O
CrystEngComm (2014) 16, 21 4365
a=5.2870(10)Å b=11.163(2)Å c=19.899(4)Å
α=90.00° β=96.704(9)° γ=90.00°
1:1 pico:mal
C9H10N2O5
CrystEngComm (2014) 16, 21 4365
a=5.1660(10)Å b=7.666(2)Å c=13.086(3)Å
α=74.730(11)° β=81.423(12)° γ=77.409(13)°
1:1 pico:man
C14H14N2O4
CrystEngComm (2014) 16, 21 4365
a=5.390(2)Å b=9.897(3)Å c=24.214(6)Å
α=90.00° β=90.699(13)° γ=90.00°
2:1 pico:glu
C8.5H10N2O3
CrystEngComm (2014) 16, 21 4365
a=21.95(2)Å b=5.220(7)Å c=17.260(19)Å
α=90.00° β=118.86(5)° γ=90.00°
Loratadine-form1
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.844(16)Å b=4.867(3)Å c=28.892(16)Å
α=90.00° β=108.98(3)° γ=90.00°
B8K4Nb4O24
B8K4Nb4O24
Acta Crystallographica Section B (2005) 61, 4 361-366
a=7.3056(11)Å b=31.1632(18)Å c=9.1659(15)Å
α=90.00° β=90.00° γ=90.00°
K Nb O B2 O5
B2KNbO6
Acta Crystallographica B (39,1983-) (2005) 61, 361-366
a=7.3056Å b=31.1632Å c=9.1659Å
α=90° β=90° γ=90°
(6R,7aS)-6-(tert-Butyl-dimethyl-silanyloxy)-1-hydroxy-2-phenyl-5,6,7,7a- tetrahydro-pyrrolizin-3-one
C19H27NO3Si
Acta Crystallographica Section B (2009) 65, 3 249-268
a=6.425(2)Å b=6.522(2)Å c=22.716(6)Å
α=90° β=90.739(11)° γ=90°
C22H22N6O7S2,5(H2O)
C22H22N6O7S2,5(H2O)
Acta Crystallographica Section B (2012) 68, 3 313-317
a=8.9716(5)Å b=10.3943(7)Å c=31.5444(12)Å
α=90.0° β=90.0° γ=90.0°
Cyclic ester of phenylalanylalanylglycylphenylalanyl(2-aminopropane)
C26H32N4O5
Acta Crystallographica Section E (2015) 71, 1 113-116
a=10.126(9)Å b=15.096(14)Å c=15.355(13)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(1<i>H</i>-pyrazole-κ<i>N</i>^2^)palladium(II) dichloride
C12H16N8Pd2,2(Cl)
Acta Crystallographica Section E (2014) 70, 12 486-488
a=13.797(3)Å b=9.6560(19)Å c=14.174(3)Å
α=90.00° β=117.80(3)° γ=90.00°
C16H20N2O
C16H20N2O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=8.695(3)Å b=10.114(3)Å c=15.544(5)Å
α=90° β=90° γ=90°
C25H31NO5
C25H31NO5
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=8.4140(10)Å b=13.760(2)Å c=19.299(2)Å
α=90° β=90° γ=90°
C21H22N2
C21H22N2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=6.0196(2)Å b=12.7041(4)Å c=21.6151(4)Å
α=90° β=90° γ=90°
C19H18N2
C19H18N2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=12.094(4)Å b=12.094(4)Å c=8.551(3)Å
α=90° β=90° γ=120°
C19H26N6O
C19H26N6O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=11.25467(7)Å b=15.43831(8)Å c=22.51824(11)Å
α=90° β=90° γ=90°
C16H18N2
C16H18N2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=11.7721(4)Å b=11.7721(4)Å c=8.0824(3)Å
α=90° β=90° γ=120°
C16H18N2
C16H18N2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=8.529(2)Å b=12.793(3)Å c=12.018(3)Å
α=90° β=94.386(11)° γ=90°
C3H7NO2
C3H7NO2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=5.791(2)Å b=5.944(2)Å c=12.269(2)Å
α=90° β=90° γ=90°
C21H29N3
C21H29N3
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=8.513(2)Å b=11.527(2)Å c=17.855(4)Å
α=90° β=90° γ=90°
C19H26N6O
C19H26N6O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=11.25751(6)Å b=15.43442(9)Å c=22.52516(13)Å
α=90° β=90° γ=90°
C5H10N2O3
C5H10N2O3
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=5.094(2)Å b=7.745(2)Å c=15.941(2)Å
α=90° β=90° γ=90°
C21H22N2
C21H22N2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=8.540(2)Å b=11.086(2)Å c=17.344(3)Å
α=90° β=90° γ=90°
C21H26N2O3
C21H26N2O3
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=7.633(2)Å b=14.455(4)Å c=16.504(4)Å
α=90° β=90° γ=90°
C18H25O2.5
C18H25O2.5
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=12.056(4)Å b=19.225(7)Å c=6.519(2)Å
α=90° β=90° γ=90°
2,2-dimethyl-2,3-dihydro-1H-2-silacyclopent[l]phenanthrene
C18H18Si
Acta Crystallographica Section C (1997) 53, 3 344-345
a=10.005(3)Å b=17.535(3)Å c=16.509(2)Å
α=90.° β=90.° γ=90.°
<i>trans</i>-Bis(perchlorato-κO)tetrakis(1H-pyrazole-κN^2^)copper(II)
C12H16Cl2CuN8O8
Acta Crystallographica Section E (2008) 64, 10 m1315
a=14.1537(11)Å b=9.9483(5)Å c=15.7414(12)Å
α=90.00° β=114.946(6)° γ=90.00°
Bromidobis[3-(1<i>H</i>-pyrazol-1-yl-κ<i>N</i>^2^)propionamide- κ<i>O</i>]copper(II) bromide methanol monosolvate
C12H18BrCuN6O2,Br,CH4O
Acta Crystallographica Section E (2012) 68, 10 m1253-m1254
a=10.5075(4)Å b=12.6951(4)Å c=15.1551(7)Å
α=90.00° β=102.821(3)° γ=90.00°
C10H17N3O5
C10H17N3O5
Journal of Organic Chemistry (2007) 72, 6353-6363
a=8.0830(10)Å b=11.4021(13)Å c=14.4056(17)Å
α=92.201(4)° β=90.443(4)° γ=104.495(5)°
C15.5H26.5N5O6.25
C15.5H26.5N5O6.25
Journal of Organic Chemistry (2007) 72, 6353-6363
a=11.230(2)Å b=13.374(3)Å c=25.007(5)Å
α=90.00° β=90.00° γ=90.00°
C27H48
C27H48
Acta crystallographica Section B, Structural science, crystal engineering and materials (2013) 69, Pt 3 249-259
a=11.375(3)Å b=10.878(3)Å c=19.501(3)Å
α=90° β=104.237(11)° γ=90°
difluoromethylcobalamin
C63H89CoF2N13O14P
Inorganic Chemistry (1999) 38, 1785-1794
a=24.075(10)Å b=21.143(3)Å c=15.981(3)Å
α=90.00° β=90.00° γ=90.00°
C38H35Ag3N13,3(F6P),2(C2H3N)
C38H35Ag3N13,3(F6P),2(C2H3N)
Organometallics (2015) 150410094812000
a=30.663(2)Å b=17.1272(9)Å c=26.0523(19)Å
α=90° β=125.735(2)° γ=90°
C44H46Ag3N14,3(F6P),C2H3N
C44H46Ag3N14,3(F6P),C2H3N
Organometallics (2015) 150410094812000
a=13.7359(9)Å b=21.8166(17)Å c=18.8472(14)Å
α=90° β=92.090(2)° γ=90°
C38H36Ag2N12,2(F6P),2(C2H3N)
C38H36Ag2N12,2(F6P),2(C2H3N)
Organometallics (2015) 150410094812000
a=15.0415(7)Å b=26.4269(12)Å c=23.8352(12)Å
α=90° β=97.795(2)° γ=90°
C42H44Ag2N12,2(F6P)
C42H44Ag2N12,2(F6P)
Organometallics (2015) 150410094812000
a=13.3327(2)Å b=24.2833(4)Å c=14.4520(3)Å
α=90° β=104.2616(8)° γ=90°
C66H72Ag4N18,4(F6P),2(C2H3N)
C66H72Ag4N18,4(F6P),2(C2H3N)
Organometallics (2015) 150410094812000
a=12.6618(4)Å b=13.2257(4)Å c=15.6462(6)Å
α=79.455(2)° β=66.860(1)° γ=70.499(2)°